AstraZeneca gets orphan drug designation for pancreatic cancer drug Lynparza Medical Dialogues Bureau24 March 2020 11:30 AM ISTUK: AstraZeneca has announced that Lynparza (olaparib) has been granted orphan drug designation (ODD) in Japan for the maintenance treatment of...